Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes

This publication has 33 references indexed in Scilit:

• Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine
  Vaccine, 2000
• Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age
  Vaccine, 2000
• Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys
  Vaccine, 1999
• Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
  Vaccine, 1996
• Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile
  Vaccine, 1995
• Current status of meningococcal group B vaccine candidates: capsular or noncapsular?
  Clinical Microbiology Reviews, 1994
• Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
  Microbiological Reviews, 1993
• Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil
  The Lancet, 1992
• The class 1 outer membrane protein of Neisseria meningitidis produced in Bacillus subtilis can give rise to protective immunity
  Molecular Microbiology, 1992
• Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
  The Lancet, 1991